Studies searching for AF serum biomarkers are not new, as several biomarkers, including troponin, brain natriuretic peptide, creatinine, C-reactive protein, and fibroblast growth factor 23, have been associated with AF pathology, progression, and treatment effects [2,9,10,11]. This evidence concerns the gene FGF23 and atrial fibrillation.